• Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 1199 / S. 1544).
• Senate and House Appropriations Committees report language on nuclear medicine event reporting. Issues related to the Department of Defense Congressionally Directed Medical Research Programs' Peer-Reviewed Cancer Research Program.
• Issues pertaining to the utility and role of nuclear medicine as it relates to the goals of the White House's Cancer Moonshot. Additionally, issues related to coverage of molecular breast imaging (MBI), including under the Find It Early Act (H.R. 3086).
• Issues related to the Nuclear Regulatory Commission's preliminary proposed rule titled, "Reporting Nuclear Medicine Injection Extravasations as Medical Events" (10 CFR 35).

Duration: December 1, 2018 to present

General Issues: Medicare/Medicaid, Budget/Appropriations, Health Issues, Energy/Nuclear, Defense

Spending: about $1,200,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2018: U.S. Senate, House of Representatives, White House Office, Executive Office of the President (EOP), Office of Science & Technology Policy (OSTP), Defense - Dept of (DOD), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)